FormWeb • cabotegravir

Cabotegravir extended-release injectable (Apretude) is Formulary, Restricted to outpatient; Utilization of an oral lead-in prior to administration of cabotegravir injection may help ensure patient-specific tolerability until more real-world data is available.

Last updated: Feb. 22, 2023

Black Box Warning: Risk of Drug Resistance with Use of Cabotegravir for HIV-1 Pre-Exposure Prophylaxis (PrEP) in Undiagnosed HIV-1 Infection
Restricted Formulary Restricted Medication

This site is intended for the staff of Legacy Health.
While others may view accessible pages, Legacy Health makes no warranty, express or implied,
as to the use of this information outside of Legacy Health.